Intestinal ultrasound for monitoring Crohn's disease
Part of Digestive system clinical trials.
This study uses an intestinal ultrasound (a safe, painless scan) to check how well Crohn's disease is controlled. It may help doctors see inflammation without more invasive tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Crohn's disease that has been present for at least 1 month.
- You are 18 years old or older.
- You are covered by French national health insurance.
- You are not pregnant or breastfeeding.
- You are not in legal custody or under guardianship.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of MRI scans to see how well they detect inflammation in the small intestine of people with Crohn's disease. It aims to find the best way to assess disease activity without invasive procedures.
This study uses intestinal ultrasound to measure Crohn's disease damage over time. It aims to see if ultrasound can replace more invasive tests like MRI or colonoscopy.
This study tests whether a small, hand-held ultrasound device can find signs of inflammation in the bowel wall of people with Crohn's disease. It may help doctors check disease activity more easily and without radiation.
This study tests if drinking water before an ultrasound helps doctors see the small bowel better in people with Crohn's disease. If your initial scan showed a narrow or thickened bowel area, you may be asked to drink water and have a second scan to see if the images improve.
This study uses intestinal ultrasound to see if vedolizumab can heal the gut in people recently diagnosed with Crohn's disease. It aims to find early signs that the treatment is working.
This study checks whether adding an extra, cross-body “transmural” evaluation (looking at inflammation throughout the bowel) improves care for adults with Crohn’s who are starting or receiving biologic (biotherapy) treatment. It uses close follow-up with stool calprotectin (a marker of gut inflammation) to see if this approach helps control inflammation.
Hear when a new Crohn Disease (CD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.